60 DEGREES PHARMACEUTICALS, INC.: cashflow_investing
| Value | {"amount": -2907, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-06-30 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3e5c7127-3ba3-4b1b-99d0-9dc98d283fc8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-23-070884Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/cashflow-investing/2022-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3e5c7127-3ba3-4b1b-99d0-9dc98d283fc8
History
- no predecessors — first report